| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $423.4M | +13.2% |
| Cost of Revenue | $328.4M | +18.1% |
| Gross Profit | $95.0M | -1.0% |
| R&D Expense | $4.9M | +25.6% |
| SG&A Expense | $43.1M | -8.9% |
| Operating Income | $44.8M | +23.8% |
| Interest Expense | $3.9M | +25.8% |
| Pre-tax Income | $41.0M | +15.8% |
| Income Tax | $9.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | +103.2% |
| Accounts Receivable | $56.4M | +23.1% |
| Inventory | $111.1M | +22.8% |
| Current Assets | $201.1M | +23.2% |
| Total Assets | $407.1M | +10.4% |
| Current Liabilities | $110.2M | +31.3% |
| Long-term Debt | $81.2M | +36.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.9M | -39.1% |
| Capital Expenditures | $8.3M | -8.8% |
| Investing Cash Flow | -$5.7M | -11.8% |
| Financing Cash Flow | -$2.0M | +87.6% |
| Free Cash Flow | $7.6M | -55.3% |
| +66.7% |
| Net Income | $26.9M | -10.0% |
| EPS (Basic) | $0.99 | -8.3% |
| EPS (Diluted) | $0.98 | -8.4% |
| Total Liabilities |
| $199.8M |
| +25.1% |
| Stockholders' Equity | $207.3M | -0.9% |